Early-Stage cancer drug trial halted after enrolling just 3 patients
NCT ID NCT03993379
Summary
This study aimed to test if a new drug called CX-072, when combined with other cancer treatments, could shrink tumors in adults with advanced solid cancers like melanoma. It was a Phase 2 trial designed to measure how well the tumors responded to treatment and to check for side effects. The trial was terminated early after enrolling only three participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, South Korea
-
Ballarat Oncology and Haematology Services
Wendouree, Victoria, Australia
-
Beacon Cancer Care
Coeur d'Alene, Idaho, 83814, United States
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Clinica Universitaria de Navarra
Pamplona, Spain
-
Columbia Medical Center
New York, New York, 10032, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hospital Clinic de Barcelona. Servicio Oncologia Medica
Barcelona, Spain
-
Hospital Universitario La Paz
Madrid, Spain
-
ICO Hospitalet, Hospital Duran I Reynals
Barcelona, 08908, Spain
-
Inova Dwight and March Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Multicare Institute for Research and Innovation
Spokane, Washington, 99204, United States
-
NYC Cancer Institute
New York, New York, 10016, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
Oregon Health & Science Center
Portland, Oregon, 97210, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
START- Madrid
Madrid, Spain
-
Samsung Medical Center
Seoul, South Korea
-
Seoul National University Hospital
Seoul, South Korea
-
Severance Hospital Yonsei University Health System
Seoul, South Korea
-
Sunshine Coast University Private Hospital
Sunshine Coast, Queensland, Australia
-
The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
The Netherlands Cancer Institute
Amsterdam, Netherlands
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
University Medical Center Groningen
Groningen, Netherlands
-
University of Chicago
Chicago, Illinois, 60637, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.